ELENAE THERAPEUTICS Trademark
Trademark Overview
On Thursday, June 9, 2022, a trademark application was filed for ELENAE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ELENAE THERAPEUTICS trademark a serial number of 97451246. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Monday, June 24, 2024. This trademark is owned by Elenae Therapeutics, Inc.. The ELENAE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Medical therapeutic preparations, namely, antisense therapeutics; therapeutics in the nature of pharmaceuticals for treatment of Duchenne Muscular Dystrophy (DMD)
research and development of gene therapeutics, namely, antisense therapeutics; research and development of anti-miRNA technology for the treatment of Duchenne Muscular Dystrophy (DMD); research and development of therapeutics for treatment of Duchenne Muscular Dystrophy (DMD); pharmaceutical and therapeutic research and development
General Information
| Serial Number | 97451246 |
| Word Mark | ELENAE THERAPEUTICS |
| Filing Date | Thursday, June 9, 2022 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Monday, June 24, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 2, 2023 |
Trademark Statements
| Goods and Services | Medical therapeutic preparations, namely, antisense therapeutics; therapeutics in the nature of pharmaceuticals for treatment of Duchenne Muscular Dystrophy (DMD) |
| NOT AVAILABLE | "THERAPEUTICS" |
| Goods and Services | research and development of gene therapeutics, namely, antisense therapeutics; research and development of anti-miRNA technology for the treatment of Duchenne Muscular Dystrophy (DMD); research and development of therapeutics for treatment of Duchenne Muscular Dystrophy (DMD); pharmaceutical and therapeutic research and development |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 22, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, June 22, 2022 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Elenae Therapeutics, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Berkeley, CA 94704 |
| Party Name | Elenae Therapeutics, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Berkeley, CA 94704 |
Trademark Events
| Event Date | Event Description |
| Monday, June 13, 2022 | NEW APPLICATION ENTERED |
| Wednesday, June 22, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, March 23, 2023 | ASSIGNED TO EXAMINER |
| Monday, March 27, 2023 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, March 27, 2023 | EXAMINERS AMENDMENT E-MAILED |
| Monday, March 27, 2023 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, March 27, 2023 | EXAMINER'S AMENDMENT ENTERED |
| Monday, March 27, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 12, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 2, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 2, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Thursday, December 14, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, June 27, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Thursday, December 14, 2023 | SOU EXTENSION 1 GRANTED |
| Thursday, December 14, 2023 | SOU EXTENSION 1 FILED |
| Monday, June 24, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, June 24, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, June 24, 2024 | SOU EXTENSION 2 FILED |
| Monday, June 24, 2024 | SOU EXTENSION 2 GRANTED |
| Saturday, December 16, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, April 23, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, April 23, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, April 23, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
